Adenomyosis Treatment
Adenomyosis Treatment
The options for this condition fall into four groups, and they are not interchangeable: measures that act on the bleeding and the pain directly, hormonal methods that suppress the cycle driving the disease, operations that reduce the disease while keeping the womb, and removal of the womb. Only the last is curative, and only the last ends fertility. The order in which they are tried is decided by how much the bleeding is costing in daily life, how much of the month the pain takes, whether a pregnancy is wanted, and which form the disease takes — because focal disease can be removed and diffuse disease cannot. Everything below is organised by that one question.
The four groups of treatment, and the one question that orders them
The reason a plan is often wrong is that it starts from the treatment rather than from what is wanted:
- Measures that act on the bleeding and the pain directly. Non-steroidal anti-inflammatory drugs and tranexamic acid reduce how much is lost and how much it hurts without suppressing the cycle, which means they can be used while a pregnancy is being attempted.
- Hormonal methods that suppress the cycle. Combined hormonal contraception, progestogens, an intrauterine system and GnRH analogues all work by reducing the drive behind the tissue. They control symptoms rather than removing the disease, and the symptoms return when they are stopped.
- Operations that reduce the disease while keeping the womb. Removing focal disease, reducing the bulk of the womb, and in selected cases embolisation of the blood supply. These are for patients who want to keep the womb or keep the possibility of pregnancy open.
- Removal of the womb. The only option that removes the disease with the organ and the only one after which the symptoms do not return. It is also the only one that ends fertility, which is why it is a decision about the whole plan rather than a last resort.
The one question that orders them. Is a pregnancy wanted, now or in the future? That single answer removes some options from the table and moves others forward, and it is why the plan is written after the question has been answered rather than before. Everything else — how much bleeding, how much pain, which form of the disease — then decides the sequence within what remains.
Measures that work on the bleeding and the pain directly
These are the first step for most patients, and their limitations are as important as their effects:
- Non-steroidal anti-inflammatory drugs. They reduce both the pain and the volume of bleeding, and they work far better taken before the pain peaks — at the first sign of the period rather than once the cramping is established, because pain that is anticipated can be pre-empted and pain that is chased is harder to control.
- Tranexamic acid on the heaviest days. It reduces the amount of blood lost by acting on the breakdown of clots, and it does so without altering the cycle. It is used on the days of heavy flow rather than continuously.
- Treating the anaemia, and checking whether there is any. Iron is not a treatment for the cause, but years of heavy loss deplete the body and correcting that is part of the plan rather than an incidental prescription. The count is measured rather than assumed.
- What they do not do. They do not reduce the size of the womb, they do not remove the disease, and they do not stop the bleeding entirely. They buy time and they make the days manageable, and they are judged by whether they do that.
Why this group is not skipped. These measures carry no effect on fertility, they can be started immediately, and they establish how much of the problem a simple approach can address. Where they are enough, nothing more is needed; where they are not, the size of the remaining problem is known rather than estimated.
Hormonal methods that suppress the cycle
These act on the drive behind the tissue rather than on the tissue itself, and that distinction explains both their benefit and their limit:
- Combined hormonal contraception. Taken continuously or with extended cycling rather than with a break each month, it reduces both the bleeding and the cyclical pain, because the withdrawal bleed is what the disease responds to. Taken with a monthly break, much of the benefit is given away.
- A progestogen, by mouth or by injection. Used where an oestrogen-containing method is unsuitable or not wanted, with the same aim of thinning the lining and reducing the bleeding.
- An intrauterine system releasing a progestogen. It acts most directly on the bleeding and reduces it substantially, and it avoids the need to remember a tablet. It is the option most often chosen when bleeding is the dominant problem and the womb is not so distorted that it cannot be fitted.
- A GnRH agonist or antagonist for a defined period. It switches off the cycle entirely, and it is used where other measures have not controlled the symptoms. It is given for a defined course with the duration set in advance, and where it is continued beyond a short course, add-back therapy is given to protect bone density. Used without a limit and without add-back, it takes bone away for no additional benefit.
- What suppression does and does not do. It controls the symptoms while it is taken. It does not remove the disease, it does not shrink it permanently, and the symptoms return when it stops. A course without a review date quietly becomes indefinite, which is why the date is written into the plan.
Why the limit is stated so plainly. Patients who expect a hormonal method to cure the condition stop taking it when the symptoms return, having concluded that it failed. Understanding from the start that it holds the symptoms down while it is taken is what makes it usable, and what makes stopping a planned decision rather than a disappointment.
Operations that keep the womb
These are the options for patients who want to keep the womb, or to keep the possibility of pregnancy open:
- Removing focal disease. Where the disease is confined to one area, that area can be removed and the rest of the womb left in place. This is the form of the disease most likely to be suitable, which is why the difference between focal and diffuse is established before the operation is offered.
- Reducing the bulk of the womb. Where the disease is diffuse, the operation reduces the thickness of the wall rather than removing the disease completely. It can improve the bleeding and the pain substantially, it does not remove the disease, and its planning has to weigh the effect on the strength of the womb against the improvement it may bring.
- Endometrial ablation, for the bleeding rather than the pain. It removes the lining, which reduces or stops the bleeding, and it does nothing for the pain, because the pain comes from the muscle and not from the lining. It is the wrong operation where pain is the main problem, and it is not a treatment for the disease itself.
- Uterine artery embolisation. It reduces the blood supply reaching the disease, which can reduce both the bleeding and the size of the womb. It is considered on its own indications rather than as a general alternative, and it is discussed with the effect on future fertility in view rather than in the abstract.
Why these are planned with the fertility question already answered. Every one of them involves a judgement about how much of the womb can be treated without compromising a future pregnancy. Making that judgement is only possible if it is known whether a pregnancy is being planned, which is why the question is asked at the start rather than deferred.
Removal of the womb, and what it does and does not mean
This is the only curative option, and it deserves to be described accurately rather than either recommended or avoided by default:
- It removes the disease along with the womb, and the symptoms do not return. That is a genuine and complete answer to a condition that no other option eliminates, and for a patient whose symptoms have dominated years of her life it can be the right answer.
- It ends fertility, and that is the decision that has to be made explicitly. It is not reversible, and it is therefore a decision about the whole plan rather than one of a series of steps. Where a pregnancy might still be wanted, this option is set aside rather than offered as a fallback.
- It does not mean the menopause, and it does not change hormones. Where the ovaries are left in place, they continue to work and the hormonal changes of the menopause do not come earlier. The widespread belief that removal of the womb brings the menopause on, or changes weight or mood by itself, is not what happens when the ovaries are preserved, and it is worth correcting because it drives decisions that are not based on it.
- Embolisation sits between the two. It keeps the womb, it can reduce the bleeding and the size of the organ, and it does not remove the disease. It is a reasonable option for some patients and unsuitable for others, and which of the two applies is established by the assessment rather than assumed.
Why the framing matters so much. Being told that removal of the womb is the only answer, before any of the other options has been tried or even described, changes what a patient believes about her own case. It is one complete option among several, and it is the right one when the others are unsuitable or have been given an adequate trial — which is a different statement from saying it is the only one.
The plan, the review date, and how long to judge
A plan for a condition that is managed over years needs to be written down, because the alternative is a sequence of appointments without a direction:
- It names what is being treated. The bleeding, the pain, or both, and whether the plan is intended to preserve the womb and fertility. Without that stated, a treatment that improves the bleeding and leaves the pain looks like a failure rather than like the partial result it was designed to be.
- It states how long the current step gets before it is judged. A hormonal method needs to be taken through a defined period before its effect can be assessed honestly, and an inadequate trial followed by a change of direction is how patients end up having tried everything and had nothing work properly.
- It names the review date and what would change the approach. Bleeding that does not reduce, pain that becomes continuous, a falling blood count, a pregnancy being wanted — each of these moves the plan on, and writing them down means the decision does not depend on remembering to raise it.
- It carries forward to wherever care continues. Results are issued with their dates and the technique used, and the plan states what has been tried, for how long and with what effect, so that the next clinician starts from the record rather than from the beginning.
Why the review date is the part patients use most. Most of the decisions in this condition are made between appointments, when the bleeding is heavier than expected or the pain has changed. Knowing when the next review is, and what would bring it forward, is what keeps a managed condition from becoming an unmanaged one.